Sentiment-Signal
Score-Verlauf (90 Tage)
Stammdaten
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Unternehmen & Branche
| Name | Surgery Partners, Inc. |
|---|---|
| Ticker | SGRY |
| CIK | 0001638833 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Care Facilities |
| SIC | 8062 · Services-General Medical & Surgical Hospitals, NEC |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 1,86 Mrd. USD |
| Beta | 1,99 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -77,900,000 | -0.61 | 8,119,700,000 | 1,712,900,000 | |
| 2025-09-30 | 10-Q | -22,700,000 | -0.18 | 7,946,600,000 | 1,729,500,000 | |
| 2025-06-30 | 10-Q | -2,500,000 | -0.02 | 7,954,800,000 | 1,748,300,000 | |
| 2025-03-31 | 10-Q | -37,700,000 | -0.30 | 7,949,200,000 | 1,740,400,000 | |
| 2024-12-31 | 10-K | -168,100,000 | -1.33 | 7,890,000,000 | 1,789,700,000 | |
| 2024-09-30 | 10-Q | -31,700,000 | -0.25 | 7,534,400,000 | 1,896,500,000 | |
| 2024-06-30 | 10-Q | -15,500,000 | -0.12 | 7,488,600,000 | 1,952,400,000 | |
| 2024-03-31 | 10-Q | -12,400,000 | -0.10 | 6,975,600,000 | 1,967,300,000 | |
| 2023-12-31 | 10-K | -11,900,000 | -0.09 | 6,876,700,000 | 1,987,200,000 | |
| 2023-09-30 | 10-Q | -4,900,000 | -0.04 | 6,780,100,000 | 2,004,600,000 | |
| 2023-06-30 | 10-Q | 18,900,000 | 0.15 | 6,620,600,000 | 2,018,200,000 | |
| 2023-03-31 | 10-Q | -24,900,000 | -0.20 | 6,643,300,000 | 1,962,000,000 | |
| 2022-12-31 | 10-K | -54,600,000 | -0.59 | 6,682,100,000 | 1,998,200,000 | |
| 2022-09-30 | 10-Q | -25,000,000 | -0.28 | 6,536,500,000 | 1,172,900,000 | |
| 2022-06-30 | 10-Q | -18,400,000 | -0.21 | 6,291,600,000 | 1,155,100,000 | |
| 2022-03-31 | 10-Q | 12,200,000 | 0.14 | 6,289,500,000 | 1,160,900,000 | |
| 2021-12-31 | 10-K | -70,900,000 | -1.12 | 6,117,600,000 | 1,089,000,000 | |
| 2021-09-30 | 10-Q | -22,900,000 | -0.28 | 5,631,600,000 | 756,300,000 | |
| 2021-06-30 | 10-Q | -26,900,000 | -0.39 | 5,620,600,000 | 765,100,000 | |
| 2021-03-31 | 10-Q | -21,000,000 | -0.57 | 5,639,000,000 | 336,500,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | Doherty David T | Officer, Chief Financial Officer | Open Market Sale | -8,867 | 12.50 | -110,837.50 | -56,8% | |
| 2026-03-16 | Evans Jason Eric | Officer, Chief Executive Officer | Open Market Sale | -20,400 | 12.47 | -254,388.00 | -130,3% | |
| 2026-03-13 | Brittenham Marissa | Officer, Chief Strategy Officer | Open Market Sale | -3,657 | 12.54 | -45,858.78 | -23,5% | |
| 2026-03-13 | Burkhalter Danielle | Officer, Chief Human Resources Officer | Open Market Sale | -3,469 | 12.83 | -44,507.27 | -22,8% | |
| 2026-03-12 | Baldock Jennifer | Officer, Chief Admin & Dev Officer | Open Market Sale | -5,798 | 13.17 | -76,359.66 | -39,1% | |
| 2026-03-06 | Brittenham Marissa | Officer, Chief Strategy Officer | Open Market Sale | -8,785 | 13.70 | -120,354.50 | -61,6% | |
| 2026-03-06 | Evans Jason Eric | Officer, Chief Executive Officer | Open Market Sale | -11,462 | 13.79 | -158,060.98 | -80,9% | |
| 2026-03-06 | Webb William Trenton | Officer, American Group President | Open Market Sale | -272 | 13.93 | -3,788.96 | -1,9% | |
| 2026-03-06 | Doherty David T | Officer, Chief Financial Officer | Open Market Sale | -14,574 | 13.84 | -201,704.16 | -103,3% | |
| 2026-03-06 | Baldock Jennifer | Officer, Chief Admin & Dev Officer | Open Market Sale | -10,082 | 13.70 | -138,123.40 | -70,7% | |
| 2026-03-06 | Burkhalter Danielle | Officer, Chief Human Resources Officer | Open Market Sale | -7,736 | 13.60 | -105,209.60 | -53,9% | |
| 2026-03-05 | Webb William Trenton | Officer, American Group President | Open Market Sale | -1,794 | 13.86 | -24,864.84 | -12,7% | |
| 2025-09-04 | Bane Harrison R. | Officer, National Group President | Open Market Sale | -5,726 | 22.48 | -128,720.48 | -65,9% | |
| 2025-09-04 | Bane Harrison R. | Officer, National Group President | Open Market Sale | -3,613 | 22.48 | -81,220.24 | -41,6% | |
| 2025-08-11 | Maryland Patricia Anne | Director | Open Market Sale | -20,018 | 22.74 | -455,209.32 | -233,1% | |
| 2025-08-11 | DeLuca Teresa | Director | Open Market Sale | -20,018 | 22.74 | -455,209.32 | -233,1% | |
| 2025-08-11 | Maryland Patricia Anne | Director | Open Market Sale | 0 | 0.00 | 0.00 | 0,0% | |
| 2025-08-08 | Doherty David T | Officer, Chief Financial Officer | Open Market Sale | -47,491 | 23.39 | -1,110,814.49 | -568,8% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.